Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q04DX003 (ip) |
median survival time |
saline |
0.75 mg/kg/injection |
108.0 |
Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
Q04DX003 (ip) |
median survival time |
saline |
1.5 mg/kg/injection |
112.0 |
Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
Q04DX003 (ip) |
median survival time |
saline |
3.0 mg/kg/injection |
131.0 |
Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
Q04DX003 (ip) |
median survival time |
saline |
6.0 mg/kg/injection |
170.0 |
Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |
Q04DX003 (ip) |
median survival time |
saline |
12.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 45; 08/08 animals surviving on day 5 |